Dose-related decrease of serum coenzyme Q10 during treatment with HMG-CoA reductase inhibitors

This publication has 10 references indexed in Scilit:

• Coenzyme Q10 as an adjunctive in the treatment of chronic congestive heart failure
  Journal of Cardiac Failure, 1995
• Perspectives on therapy of cardiovascular diseases with oenzyme Q10 (Ubiquinone)
  Journal of Molecular Medicine, 1993
• Vitamin E Consumption and the Risk of Coronary Heart Disease in Men
  New England Journal of Medicine, 1993
• Vitamin E Consumption and the Risk of Coronary Disease in Women
  New England Journal of Medicine, 1993
• Evidence of Plasma CoQ10‐Lowering Effect by HMG‐CoA Reductase Inhibitors: A Double‐Blind, Placebo‐Controlled Study
  The Journal of Clinical Pharmacology, 1993
• Dietary supplementation with coenzyme Q10 results in increased levels of ubiquinol-10 within circulating lipoproteins and increased resistance of human low-density lipoprotein to the initiation of lipid peroxidation
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1992
• Ratio of Low-Density Lipoprotein Cholesterol to Ubiquinone as a Coronary Risk Factor
  New England Journal of Medicine, 1991
• Co‐Enzyme Q₁₀: A New Drug for Cardiovascular Disease
  The Journal of Clinical Pharmacology, 1990
• Determination of coenzyme Q10, α-tocopherol and cholesterol in biological samples by coupled-column liquid chromatography with coulometric and ultraviolet detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1988
• Transport of [14C]coenzyme Q10 from the liver to other tissues after intravenous administration to guinea pigs
  Biochimica et Biophysica Acta (BBA) - General Subjects, 1983